NZ181221A - A pharmaceutical composition comprising a quinazolone for prevention of gastro-intestinal ulcers caused by a non-steroid anti-inflammatory agent in the composition - Google Patents
A pharmaceutical composition comprising a quinazolone for prevention of gastro-intestinal ulcers caused by a non-steroid anti-inflammatory agent in the compositionInfo
- Publication number
- NZ181221A NZ181221A NZ181221A NZ18122176A NZ181221A NZ 181221 A NZ181221 A NZ 181221A NZ 181221 A NZ181221 A NZ 181221A NZ 18122176 A NZ18122176 A NZ 18122176A NZ 181221 A NZ181221 A NZ 181221A
- Authority
- NZ
- New Zealand
- Prior art keywords
- composition
- quinazolone
- gastro
- prevention
- inflammatory agent
- Prior art date
Links
- 206010061459 Gastrointestinal ulcer Diseases 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US58957375A | 1975-06-23 | 1975-06-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ181221A true NZ181221A (en) | 1978-04-28 |
Family
ID=24358582
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ181221A NZ181221A (en) | 1975-06-23 | 1976-06-21 | A pharmaceutical composition comprising a quinazolone for prevention of gastro-intestinal ulcers caused by a non-steroid anti-inflammatory agent in the composition |
Country Status (11)
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1251600A (enrdf_load_html_response) | 1968-07-18 | 1971-10-27 | ||
| US3712892A (en) | 1969-08-02 | 1973-01-23 | Sumitomo Chemical Co | Quinazolinone derivatives |
| US3859237A (en) | 1970-04-20 | 1975-01-07 | Sumitomo Chemical Co | Quinazoline derivatives |
| GB1307202A (en) | 1971-06-15 | 1973-02-14 | Sumitomo Chemical Co | Quinazoline derivative a process for producing them and compositions containing them |
-
1976
- 1976-05-26 JP JP51061613A patent/JPS521036A/ja active Granted
- 1976-06-16 NL NL7606494A patent/NL7606494A/xx not_active Application Discontinuation
- 1976-06-18 AU AU15066/76A patent/AU499021B2/en not_active Expired
- 1976-06-21 NZ NZ181221A patent/NZ181221A/xx unknown
- 1976-06-21 CA CA255,289A patent/CA1062615A/en not_active Expired
- 1976-06-21 FR FR7618763A patent/FR2315281A1/fr active Granted
- 1976-06-22 IL IL49867A patent/IL49867A/xx unknown
- 1976-06-22 BE BE168174A patent/BE843242A/xx not_active IP Right Cessation
- 1976-06-22 GB GB25956/76A patent/GB1507804A/en not_active Expired
- 1976-06-22 DE DE19762627914 patent/DE2627914A1/de not_active Withdrawn
- 1976-06-22 ZA ZA763700A patent/ZA763700B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JPS521036A (en) | 1977-01-06 |
| DE2627914A1 (de) | 1977-01-13 |
| FR2315281B1 (enrdf_load_html_response) | 1979-04-27 |
| AU499021B2 (en) | 1979-04-05 |
| NL7606494A (nl) | 1976-12-27 |
| BE843242A (fr) | 1976-10-18 |
| IL49867A (en) | 1980-01-31 |
| FR2315281A1 (fr) | 1977-01-21 |
| AU1506676A (en) | 1977-12-22 |
| GB1507804A (en) | 1978-04-19 |
| CA1062615A (en) | 1979-09-18 |
| JPS5416509B2 (enrdf_load_html_response) | 1979-06-22 |
| IL49867A0 (en) | 1976-08-31 |
| ZA763700B (en) | 1977-05-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1131A (en) | Pharmaceutical compositions for use in the suppression of gastric reflux | |
| PH15369A (en) | Orally administrable pharmaceutical composition | |
| ZA763652B (en) | Pharmacologically active compounds | |
| ZM12176A1 (en) | Pharmacologically active compounds | |
| ZA763917B (en) | Pharmaceutical compositions and compounds | |
| ZA767198B (en) | Pharmacologically active compounds | |
| ZM9876A1 (en) | Pharmacologically active compounds | |
| GB1550139A (en) | Anti-inflammatory compositions for oral application | |
| ZA7682B (en) | Pharmacologically active compounds | |
| CY1153A (en) | Pharmaceutical compositions | |
| PT65377A (en) | Pharmacologically active compounds | |
| ZM9776A1 (en) | Pharmacologically active compounds | |
| ZA761324B (en) | Pharmaceutically active compounds | |
| IL50174A0 (en) | Pharmaceutical compositions comprising an anti-inflammatory compound and a gastric lesions formation inhibitor | |
| PT65839A (en) | Pharmacologically active compounds | |
| ZA762536B (en) | Pharmacologically active compounds | |
| NZ181221A (en) | A pharmaceutical composition comprising a quinazolone for prevention of gastro-intestinal ulcers caused by a non-steroid anti-inflammatory agent in the composition | |
| PT68422A (en) | Anti-inflammatory 1-phenylethanolamine derivatives pharmaceutical compositions thereof and processes for their manufacture | |
| GB2004742B (en) | Anti-inflammatory pharmaceutical compositions | |
| IE42772L (en) | Pharmaceutical compositions | |
| GB1552416A (en) | Pharmaceutical compositions | |
| AU1059176A (en) | Pharmacologically active compositions | |
| AU1172076A (en) | Pharmaceutical compositions | |
| PT65759A (en) | Pharmacologically active compounds | |
| GB1540812A (en) | Anti-inflammatory pharmaceutical compositions |